Breast Cancer

33 Expert Conversations

    33 Expert Conversations
      Breast cancer hormone therapy. LHRH agonists. Tamoxifen. SERDs. Aromatase inhibitors. SERMs. 4
      Dr. Marc Lippman. Breast Cancer hormone therapy expert. Biography. 0
      Breast cancer hormone therapy. LHRH agonists or bilateral salpingo-oophorectomy (BSO)? 9
      When can breast cancer be considered cured? Is cure possible for breast cancer? 5
      Breast cancer treatment. How to select neoadjuvant and adjuvant chemotherapy? 10
      Hormone therapy for breast cancer. History and advances. 1
      Breast cancer hormone therapy. Opposing progestins to prevent or treat breast cancer? 7
      Immunotherapy in breast cancer. Immunotherapy is not a magic treatment. 11
      Breast cancer hormone therapy. How to choose aromatase inhibitors? 8
      Breast cancer hormone therapy. Tamoxifen vs. Anastrozole? 3
      How to prevent 70% of breast cancers? Tamoxifen. Aromatase inhibitors. 2
      Breast cancer hormone therapy. 5 or 10 years for Aromatase inhibitors? Estrogens promote breast cancer. 6
      Test How to prevent 70% of breast cancers? Tamoxifen. Aromatase inhibitors. 2
      Breast cancer immunotherapy. Triple-negative breast cancer. Antibody-drug conjugates. 6
      Hormonal treatment of breast cancer. Professor Marc E. Lippman.
      Seek second opinion from a clinical physician or surgeon. Not from a radiologist. 15
      Breast cancer, obesity, and insulin. How metformin helps to delay cancer. 3
      Hormone-resistant breast cancer. New endocrine therapy of cancer. 2
      How to prevent breast cancer? Chemoprevention with aromatase inhibitors. 10
      Early breast cancer, DCIS. How to decide on best therapy? 3
      Tumor markers in DCIS breast cancer. Prediction of endocrine treatment and radiotherapy. 2
      Ductal Carcinoma In Situ, DCIS. Treatment and prevention. 1
      ‘You must give the patient a human touch.’ Top breast cancer expert shares wisdom. 10
      Metastatic triple-negative breast cancer. Long-term survival. Clinical case. 9
      Future in breast cancer therapy. Deescalation of treatment. Cure of metastatic cancer? 8
      Immunotherapy side effects in breast cancer patients. 7
      Triple-negative breast cancer therapy. Neoadjuvant therapy indications. 5
      HER2-positive breast cancer therapy. Tucatinib. Trastuzumab deruxtecan. 4
      Hormone-positive, 
HER2-negative breast cancer. Antibody-drug conjugates. 3
      Precision medicine in breast cancer therapy. Targeted drugs 
or chemotherapy? 2
      Targeted therapy for breast cancer. What are the molecular targets of drugs? 1
      Dr. Giuseppe Curigliano. Breast cancer therapy expert. Biography. 0
      Locally recurrent breast cancer treatment. 6
      Recently viewed Expert Conversations